PIPC Reminds Democrats The Party Promised To Not Use QALYs

By John Wilkerson / March 22, 2021 at 5:59 PM
In preparation for a Senate hearing that will highlight lower foreign drug prices, a coalition that includes drug makers and patients is reminding Democrats that their 2020 party platform opposes using a metric that is key to drug-value assessments: quality-adjusted life years (QALY). On Tuesday (March 23), the labor subcommittee of the Senate health committee will hold a hearing titled, “Why Does the US Pay the Highest Prices in the World for Prescription Drugs?” The hearing, scheduled by subcommittee Chair...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.